Combination of AS101 and Mefloquine Inhibits Carbapenem-Resistant Pseudomonas aeruginosa in vitro and in vivo.
Rongrong LiXuhang ShenZhengyuan LiJi-Long ShenHao TangHuaming XuJilu ShenYuanhong XuPublished in: Infection and drug resistance (2023)
The present study showed that the combination of AS101 and mefloquine yielded a notable synergistic bacteriostatic effect both in vitro and in vivo, suggesting a potential clinical application of this combination in the treatment of CRPA.